Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
General Counsel
Collegium Pharmaceutical, Inc (COLL)Equibles does not estimate personal net worth.
Get an email with a short summary when Collegium Pharmaceutical, Inc publishes a filing, an earnings call transcript or a press release.
Get COLL alertsDavid Dieter is recorded as General Counsel at Collegium Pharmaceutical, Inc (COLL). Collegium Pharmaceutical, Inc reported in an 8-K filed March 17, 2025 that David Dieter was appointed Executive Vice President and General Counsel, effective March 17, 2025. The proxy statement of Collegium Pharmaceutical, Inc reports total compensation of $3,870,092 for David Dieter in fiscal 2025, including a base salary of $384,615. Disclosed compensation is on record for 3 fiscal years. Collegium Pharmaceutical, Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Collegium Pharmaceutical, Inc includes Gino Santini (Chairman and Board Member), Shirley Kuhlmann (General Counsel), Carlos Paya (Board Member) and 7 others.
“On March 17, 2025, the Company announced the appointment of David Dieter to serve as Executive Vice President and General Counsel, effective March 17, 2025.”
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Collegium Pharmaceutical, Inc (COLL) | Executive Vice President and General Counsel | $384,615 | $3,870,092 |
| 2024 | Collegium Pharmaceutical, Inc (COLL) | Executive Vice President and General Counsel | — | — |
| 2023 | Collegium Pharmaceutical, Inc (COLL) | Executive Vice President and General Counsel | — | — |